Inhibitor Therapeutics, Inc. (INTI)
OTCMKTS · Delayed Price · Currency is USD
0.0900
0.00 (0.00%)
May 5, 2026, 4:00 PM EST
Inhibitor Therapeutics Market Cap
Inhibitor Therapeutics has a market cap or net worth of $15.53 million as of May 6, 2026. Its market cap has increased by 12.66% in one year.
Market Cap
15.53M
Enterprise Value
13.22M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since October 29, 1997, Inhibitor Therapeutics's market cap has increased from 14.08M to 15.53M, an increase of 10.34%. That is a compound annual growth rate of 0.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 15.53M | 100.00% |
| Dec 31, 2025 | 7.77M | -25.02% |
| Dec 31, 2024 | 10.36M | -34.56% |
| Dec 28, 2023 | 15.83M | -57.47% |
| Dec 28, 2022 | 37.21M | -34.06% |
| Dec 30, 2021 | 56.43M | 332.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arch Biopartners | 21.10M |
| Anebulo Pharmaceuticals | 18.76M |
| ZIVO Bioscience | 17.01M |
| Oncotelic Therapeutics | 16.97M |
| Zeo ScientifiX | 16.49M |
| HOOKIPA Pharma | 15.30M |
| LianBio | 15.14M |
| Galera Therapeutics | 14.84M |